Key Financial Data Of Group

COSMOS Pharmaceutical Corporation - Filing #7341374

Concept 2023-06-01 to
2024-02-29
As at
2024-02-29
2023-12-01 to
2024-02-29
As at
2023-05-31
2022-06-01 to
2023-05-31
As at
2023-02-28
2022-12-01 to
2023-02-28
2022-06-01 to
2023-02-28
Key financial data of group
Business results of group
Net sales
715,311,000,000 JPY
827,697,000,000 JPY
606,302,000,000 JPY
Ordinary profit (loss)
25,914,000,000 JPY
33,086,000,000 JPY
24,393,000,000 JPY
Profit (loss) attributable to owners of parent
17,357,000,000 JPY
23,797,000,000 JPY
16,283,000,000 JPY
Comprehensive income
17,354,000,000 JPY
23,832,000,000 JPY
16,291,000,000 JPY
Net assets
224,281,000,000 JPY
211,072,000,000 JPY
203,530,000,000 JPY
Total assets
430,241,000,000 JPY
420,967,000,000 JPY
376,930,000,000 JPY
Basic earnings (loss) per share
438.14
145.61
600.96
125.88
411.22
Diluted earnings per share
Equity-to-asset ratio
0.521 xbrli:pure
0.501 xbrli:pure
0.540 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.